Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 51: 1-2, 2005; 10.1373/clinchem.2004.040832
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (11)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Coombes, K. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Coombes, K. R.
Related Collections
Right arrow General Clinical Chemistry
Right arrow Proteomics and Protein Markers
Right arrow Automation and Analytical Techniques
(Clinical Chemistry. 2005;51:1-2.)
© 2005 American Association for Clinical Chemistry, Inc.

Editorials

Analysis of Mass Spectrometry Profiles of the Serum Proteome

Kevin R. Coombes

1 Department of Biostatistics and Applied Mathematics, University of Texas, M.D. Anderson Cancer Center, Houston, TX 77030

The first 20% of the full text of this article appears below.

Mass spectrometry is increasingly being applied to sift through complex protein mixtures to find biomarker patterns that can be used for diagnosis, prognosis, or monitoring of disease. Although some studies have directly examined tumor tissue, most have targeted easily accessible fluids, including urine, nipple aspirate fluid, cerebrospinal fluid, plasma, and most commonly, serum. A few studies have been performed on high-resolution instruments using a matrix-assisted laser desorption/ionization (MALDI) ion source and a time-of-flight (TOF) ion detector. The majority, however, have used lower resolution instruments and surface-enhanced laser desorption/ionization (SELDI), a variant of MALDI that relies on commercially prepared surfaces (ProteinChips®), to perform protein isolation or separation.

To date, the technology has primarily been applied to search for cancer biomarkers, with some success. It is now clear that SELDI profiling of the proteome can successfully detect anonymous proteins that are produced at higher (or lower) concentrations in the tissues or fluids of cancer patients than in healthy individuals (1)(2)(3). There is also preliminary evidence that we may be able to discover patterns that can reliably distinguish cancer patients from . . . [Full Text of this Article]




The following articles in journals at HighWire Press have cited this article:


Home page
 Clin. Cancer Res.Home page
B. H.L. Goulart, J. W. Clark, H. H. Pien, T. G. Roberts, S. N. Finkelstein, and B. A. Chabner
Trends in the Use and Role of Biomarkers in Phase I Oncology Trials
Clin. Cancer Res., November 15, 2007; 13(22): 6719 - 6726.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
H. Zhang and D. W. Chan
Cancer Biomarker Discovery in Plasma Using a Tissue-targeted Proteomic Approach
Cancer Epidemiol. Biomarkers Prev., October 1, 2007; 16(10): 1915 - 1917.
[Full Text] [PDF]

Home page
 Mol. Biol. CellHome page
N. Filigheddu, V. F. Gnocchi, M. Coscia, M. Cappelli, P. E. Porporato, R. Taulli, S. Traini, G. Baldanzi, F. Chianale, S. Cutrupi, et al.
Ghrelin and Des-Acyl Ghrelin Promote Differentiation and Fusion of C2C12 Skeletal Muscle Cells
Mol. Biol. Cell, March 1, 2007; 18(3): 986 - 994.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. ProteomicsHome page
T. W. Randolph, B. L. Mitchell, D. F. McLerran, P. D. Lampe, and Z. Feng
Quantifying Peptide Signal in MALDI-TOF Mass Spectrometry Data
Mol. Cell. Proteomics, December 1, 2005; 4(12): 1990 - 1999.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
R. E. Banks, A. J. Stanley, D. A. Cairns, J. H. Barrett, P. Clarke, D. Thompson, and P. J. Selby
Influences of Blood Sample Processing on Low-Molecular-Weight Proteome Identified by Surface-Enhanced Laser Desorption/Ionization Mass Spectrometry
Clin. Chem., September 1, 2005; 51(9): 1637 - 1649.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
E. T. Fung and E. Gavin
Analysis of Mass Spectrometry Profiles of the Serum Proteome
Clin. Chem., July 1, 2005; 51(7): 1309 - 1309.
[Full Text] [PDF]

Home page
 Clin. Chem.Home page
K. R. Coombes
Analysis of Mass Spectrometry Profiles of the Serum Proteome - Reply
Clin. Chem., July 1, 2005; 51(7): 1309 - 1309.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American Association for Clinical Chemistry.